Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study
- 260 Downloads
The purpose of this study was to examine gender- and age-specific prevalence, incidence, and the type of anti-asthma medications used in the Norwegian population aged 2–29 years during 2005–2007 and to estimate the share of individuals who regularly redeemed medications over a 3-year period.
We retrieved data from the nationwide Norwegian Prescription Database for all individuals 2–29 years old (n = 1.7 million) who received anti-asthma medications during 2005–2007. Medications included inhaled short- and long-acting β2-agonists, inhaled corticosteroids, fixed-dose combinations of inhaled β2-agonists and corticosteroids, and leukotriene antagonists.
In 2007, 5.5% (92,074 individuals) of Norwegians aged 2–29 years received anti-asthma medication, and this figure was stable throughout 2005–2007. Prevalence and incidence were higher among males than females but shifted to female dominance during adolescence. The share of anti-asthma medication users who received inhaled corticosteroids was high in preschool children but decreased by age. Conversely, use of inhaled β2-agonists as monotherapy and of fixed combinations increased with age. Fewer than half the individuals were “persistent” to medication treatment for 3 years by redeeming prescriptions regularly (at least once a year).
In this nationwide study, annual prevalence of anti-asthma medication use was stable during 2005–2007. The gender- and age-specific profile of prevalence and incidence correspond well with other studies. Fewer than half the individuals redeemed prescriptions regularly over 3 years.
KeywordsAsthma Norway Pharmacoepidemiology Prescription database
- 1.The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee (1998) Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351:1225–1232Google Scholar
- 5.Burney P (2002) The changing prevalence of asthma? Thorax 57:36–39Google Scholar
- 6.National Heart Lung and Blood Institute (NHLBI) (2007) Expert Panel Report 3 (EPR3): guidelines for the diagnosis and management of asthmaGoogle Scholar
- 7.Global Initiative for Asthma (GINA) (2007) Global strategy for asthma management and preventionGoogle Scholar
- 9.Furu K (2008) Establishment of the nationwide Norwegian Prescription Database (NorPD)—new opportunities for research in pharmacoepidemiology in Norway. Nor J Epidemiol 18:129–136Google Scholar
- 10.WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health (2008) Guidelines for ATC classification and DDD assignment. Norway, OsloGoogle Scholar
- 21.de Vries TW, Tobi H, Schirm E, van den Berg P, Duiverman EJ, de Jong-Van den Berg LT (2006) The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands. Eur J Clin Pharmacol 62:51–55Google Scholar